Ann Marie Rogers
Encyclopedia
Ann Marie Rogers was a British
campaigner who fought a successful landmark court battle to receive the breast cancer
drug Herceptin on the NHS.
Following her diagnosis with the disease and chemotherapy and radiotherapy, Swindon Primary Care Trust refused to pay for the Herceptin which could extend her life.
She borrowed £5,000 to pay for the drug, hailed by specialists as 'the biggest breakthrough in 20 years' privately and decided to go further after reading in the Daily Mail
about the possibility of legal action. She was the first woman to pursue a legal challenge when Swindon primary care trust denied her the drug.
Rogers originally lost her High Court
case, but took it to the Court of Appeal in April 2006 who overturned the original ruling.
Yogi Amin, from law firm Irwin Mitchell, who represented Ms Rogers throughout her legal battle, said that her courage had paved the way for thousands of women throughout the UK to benefit from Herceptin. The drug was fast-tracked for use on the NHS as a result.
Herceptin (trastuzumab) is a treatment for women with breast cancer whose tumors have too much HER2 protein. This type of cancer is known as "HER2-positive", "HER2+", or "HER2 overexpressing". HER2+ tumors tend to grow and spread more quickly than tumors that are not HER2+. In 2006, Herceptin was approved for the adjuvant treatment of HER2+ breast cancer.
“She was genuinely an inspiration to be around and showed tremendous courage and determination"
Rogers died on March 2, 2009, aged 57; survived by three children.
United Kingdom
The United Kingdom of Great Britain and Northern IrelandIn the United Kingdom and Dependencies, other languages have been officially recognised as legitimate autochthonous languages under the European Charter for Regional or Minority Languages...
campaigner who fought a successful landmark court battle to receive the breast cancer
Breast cancer
Breast cancer is cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk. Cancers originating from ducts are known as ductal carcinomas; those originating from lobules are known as lobular carcinomas...
drug Herceptin on the NHS.
Following her diagnosis with the disease and chemotherapy and radiotherapy, Swindon Primary Care Trust refused to pay for the Herceptin which could extend her life.
She borrowed £5,000 to pay for the drug, hailed by specialists as 'the biggest breakthrough in 20 years' privately and decided to go further after reading in the Daily Mail
Daily Mail
The Daily Mail is a British daily middle-market tabloid newspaper owned by the Daily Mail and General Trust. First published in 1896 by Lord Northcliffe, it is the United Kingdom's second biggest-selling daily newspaper after The Sun. Its sister paper The Mail on Sunday was launched in 1982...
about the possibility of legal action. She was the first woman to pursue a legal challenge when Swindon primary care trust denied her the drug.
Rogers originally lost her High Court
High Court of Justice
The High Court of Justice is, together with the Court of Appeal and the Crown Court, one of the Senior Courts of England and Wales...
case, but took it to the Court of Appeal in April 2006 who overturned the original ruling.
Yogi Amin, from law firm Irwin Mitchell, who represented Ms Rogers throughout her legal battle, said that her courage had paved the way for thousands of women throughout the UK to benefit from Herceptin. The drug was fast-tracked for use on the NHS as a result.
Herceptin (trastuzumab) is a treatment for women with breast cancer whose tumors have too much HER2 protein. This type of cancer is known as "HER2-positive", "HER2+", or "HER2 overexpressing". HER2+ tumors tend to grow and spread more quickly than tumors that are not HER2+. In 2006, Herceptin was approved for the adjuvant treatment of HER2+ breast cancer.
“She was genuinely an inspiration to be around and showed tremendous courage and determination"
Rogers died on March 2, 2009, aged 57; survived by three children.